Cognitive Neuroscience and Psychology

Cognitive impairment is when a person has trouble learning new things remembering, making decisions or concentrating that affect their everyday routine life. Cognitive impairment may range from mild to severe. People with mild impairment may begin to notice changes in cognitive functions, but still be able to do everyday activities. On the other hand people with severe levels of impairment can lead to losing the ability to understand the importance of something and the ability to write or talk, resulting in dependency on others.

Cognative impairment conference will provide information regarding  the current research and trends in Cognative impairment field.
The main topics discussed in conference Cognitive Genomics, Cognitive Dysfunction, Cognitive Development, Neurological Disorders, Cognitive neural network, Cognitive Disorder Causes,  diagnosis , Treatment and management, Neurogenetics, Cognitive Neuropsychology, Brain Behaviour and Cognitive sciences,

The global amnesia therapeutics market was worth $112m in 2011, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 3.5% to reach $147m by 2019. This growth is primarily attributed to the increase in the general population and diagnosis rate across the seven major markets (the US, the UK, Japan, Germany, Spain, Italy and France).

Sessions:
Cognitive Genomics, Cognitive Dysfunction, Cognitive Development, Neurological Disorders, Cognitive neural network, Cognitive Disorder Causes,  diagnosis , Treatment and management, Neurogenetics, Cognitive Neuropsychology, Brain Behaviour and Cognitive sciences. 

Target Audience :

Neuroscientists, Neurologists, Directors, Physicians, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students

Tags :

neurology,neurology2021,neurologyconference,neurologycongress,neuroscience,neuroscienceconference,neuroscience2021,neurosciencecongress,dementiaconference,neurologymeetings,neurologysummit,neuroscienceconferences,dementiacongress,neurologyeurope,neurologistconference,neuroscientist,dementia,alzheimersdisease